These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8547111)

  • 41. Incidence of Red Cell Alloantibody among the Transfusion Recipients of Universiti Kebangsaan Malaysia Medical Centre.
    Yousuf R; Abdul Aziz S; Yusof N; Leong CF
    Indian J Hematol Blood Transfus; 2013 Jun; 29(2):65-70. PubMed ID: 24426338
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-Jk
    Kay B; Poisson JL; Tuma CW; Shulman IA
    Transfusion; 2016 Dec; 56(12):2973-2979. PubMed ID: 27596036
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of previous erythrocyte alloimmunization and the type and screen at a large cancer center. A 4-year retrospective review.
    Havemann H; Lichtiger B
    Cancer; 1992 Jan; 69(1):252-5. PubMed ID: 1727671
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel association between high red blood cell alloimmunization rates and hereditary hemorrhagic telangiectasia.
    Zheng Y; Pollak J; Henderson K; Hendrickson JE; Tormey CA
    Transfusion; 2018 Mar; 58(3):775-780. PubMed ID: 29210083
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Delayed Serological Transfusion Reaction After Platelet Transfusion Due to Anti-e.
    Sachan D; Kumar A; Jothimani D; Rela M
    Indian J Hematol Blood Transfus; 2016 Jun; 32(Suppl 1):287-9. PubMed ID: 27408414
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk of maternal alloimmunization in Southern Pakistan - a study in a cohort of 1000 pregnant women.
    Karim F; Moiz B; Kamran N
    Transfus Apher Sci; 2015 Feb; 52(1):99-102. PubMed ID: 25532481
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Frequency of red cell alloimmunization in patients with sickle cell anemia in an Egyptian referral hospital.
    Aly R; El-sharnoby MR; Hagag AA
    Transfus Apher Sci; 2012 Dec; 47(3):253-7. PubMed ID: 22980915
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Estimation of combat-related blood group alloimmunization and delayed serologic transfusion reactions in U.S. military veterans.
    Tormey CA; Stack G
    Mil Med; 2009 May; 174(5):503-7. PubMed ID: 20731281
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hemolytic transfusion reaction due to anti-Kell undetectable in low-ionic-strength solutions.
    Molthan L; Strohm PL
    Am J Clin Pathol; 1981 Apr; 75(4):629-31. PubMed ID: 7223723
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fatal Delayed Haemolytic Transfusion Reaction and Hyperhaemolysis Syndrome in a Pregnant Woman with Sickle Cell Anaemia.
    Asnawi AW; Sathar J; Mohamed R; Deraman R; Kumaran S; Hamid SS; Zakaria MZ
    Indian J Hematol Blood Transfus; 2016 Jun; 32(Suppl 1):251-3. PubMed ID: 27408406
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A review of in vitro methods to predict the clinical significance of red blood cell alloantibodies.
    Nance SJ
    Immunohematology; 2018 Jan; 33(1):11-15. PubMed ID: 29608322
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease.
    Fasano RM; Booth GS; Miles M; Du L; Koyama T; Meier ER; Luban NL
    Br J Haematol; 2015 Jan; 168(2):291-300. PubMed ID: 25256676
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lower alloimmunization rates in pediatric sickle cell patients on chronic erythrocytapheresis compared to chronic simple transfusions.
    Wahl SK; Garcia A; Hagar W; Gildengorin G; Quirolo K; Vichinsky E
    Transfusion; 2012 Dec; 52(12):2671-6. PubMed ID: 22519830
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Delayed hemolytic transfusion reaction with four antibodies undetected by pretransfusion tests.
    Moncrieff RE; Thompson WP
    Am J Clin Pathol; 1975 Aug; 64(2):251-3. PubMed ID: 1155388
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictors of Red Cell Alloimmunization in Kurdish Multi Transfused Patients with Hemoglobinopathies in Iraq.
    Al-Mousawi MM; Al-Allawi NA; Alnaqshabandi R
    Hemoglobin; 2015; 39(6):423-6. PubMed ID: 26327166
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Red cell immunization in beta thalassaemia major.
    Bhatti FA; Salamat N; Nadeem A; Shabbir N
    J Coll Physicians Surg Pak; 2004 Nov; 14(11):657-60. PubMed ID: 15530273
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Delayed hemolytic transfusion reactions. Evidence of the need for an improved pretransfusion compatibility test.
    Moore SB; Taswell HF; Pineda AA; Sonnenberg CL
    Am J Clin Pathol; 1980 Jul; 74(1):94-7. PubMed ID: 7395821
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Prevalence of Red Blood Cell Alloantibodies in Lower Northern Thailand.
    Po-ngernnak P; Sasjeenpong S; Chuesakul K; Pangwangthong K
    J Med Assoc Thai; 2016 Dec; 99(12):1337-43. PubMed ID: 29952524
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical presentation of haemolytic transfusion reactions.
    Webster BH
    Anaesth Intensive Care; 1980 May; 8(2):115-9. PubMed ID: 7396174
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Red blood cell alloimmunization in neonates and children up to 3 years of age.
    Türkmen T; Qiu D; Cooper N; Sachs UJ; Wößmann W; Schranz D; Zimmer KP; Ehrhardt H; Hackstein H; Bein G
    Transfusion; 2017 Nov; 57(11):2720-2726. PubMed ID: 28880379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.